Variant report
Variant | esv3489639 |
---|---|
Chromosome Location | chr11:101444553-101445498 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs567113757 | chr11:101444651-101444652 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs536238883 | chr11:101444652-101444653 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs375584806 | chr11:101444675-101444676 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs150134652 | chr11:101444678-101444679 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs80170162 | chr11:101444685-101444686 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs58766729 | chr11:101444688-101444689 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs11224874 | chr11:101444689-101444690 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs57878426 | chr11:101444697-101444698 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs72976319 | chr11:101444722-101444723 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs372635385 | chr11:101444727-101444728 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs561483708 | chr11:101444777-101444778 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs10895144 | chr11:101444783-101444784 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs386756872 | chr11:101444788-101444789 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs10895145 | chr11:101444790-101444791 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs10895146 | chr11:101444805-101444806 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs555037253 | chr11:101444838-101444839 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs574787593 | chr11:101444843-101444844 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs530869044 | chr11:101444847-101444848 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs373571426 | chr11:101444859-101444860 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs564197947 | chr11:101444910-101444911 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs540610984 | chr11:101444963-101444964 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs11224875 | chr11:101444978-101444979 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs11224876 | chr11:101445006-101445007 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs566834805 | chr11:101445040-101445041 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs369415874 | chr11:101445061-101445062 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs61918375 | chr11:101445073-101445074 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs565027188 | chr11:101445090-101445091 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs530642548 | chr11:101445141-101445142 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs11224877 | chr11:101445152-101445153 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs561014682 | chr11:101445184-101445185 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs7129301 | chr11:101445189-101445190 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs546152110 | chr11:101445251-101445252 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs187645399 | chr11:101445273-101445274 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs61918376 | chr11:101445275-101445276 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs552361768 | chr11:101445309-101445310 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs569390529 | chr11:101445322-101445323 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs538431532 | chr11:101445348-101445349 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs554795985 | chr11:101445369-101445370 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs574860745 | chr11:101445444-101445445 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs148057811 | chr11:101445479-101445480 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs141792199 | chr11:101445482-101445483 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 22429812 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Melanoma | 22183965 | CNVD |
Breast cancer | 21958427 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 17603634 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Basal cell lymphoma | 16790693 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Breast cancer | 21364760 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Mental retardation | 19966786 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Cancer | 20164920 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:101426400-101447600 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
2 | chr11:101438400-101445400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
3 | chr11:101443800-101446000 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
4 | chr11:101444200-101445000 | Enhancers | NHLF | lung |
5 | chr11:101444400-101444800 | Enhancers | Fetal Lung | lung |
6 | chr11:101444400-101449200 | Enhancers | NHDF-Ad | bronchial |
7 | chr11:101444800-101446000 | Weak transcription | Fetal Lung | lung |
8 | chr11:101445000-101446000 | Weak transcription | NHLF | lung |
9 | chr11:101445400-101447800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |